Obese patients are highly sensitive to adriamycin (ADR)-induced cardiotoxicity. However, the potential mechanism of superimposed toxicity remains to be elucidated. Sestrin 2 (SESN2), a potential antioxidant, could attenuate stress-induced cardiomyopathy; therefore, this study aims to explore whether SESN2 enhances cardiac resistance to ADR-induced oxidative damage in high-fat diet (HFD)–induced obese mice.
Results:
The results revealed that obesity decreased SESN2 expression in ADR-exposed heart. And, HFD mice may predispose to ADR-induced cardiotoxicity, which was probably associated with inhibiting protein kinase B (AKT), glycogen synthase kinase-3 beta (GSK-3β) phosphorylation and subsequently blocking nuclear localization of nuclear factor erythroid-2 related factor 2 (NRF2), ultimately resulting in cardiac oxidative damage. However, these destructive cascades and cardiac oxidative damage effects induced by HFD/sodium palmitate combined with ADR were blocked by overexpression of SESN2. Moreover, the antioxidant effect of SESN2 could be largely abolished by sh-Nrf2 or wortmannin. And sulforaphane, an NRF2 agonist, could remarkably reverse cardiac pathological and functional abnormalities caused by ADR in obese mice.
Innovation and Conclusion:
This study demonstrated that SESN2 might be a promising therapeutic target for improving anthracycline-related cardiotoxicity in obesity by upregulating activity of NRF2 via AKT/GSK-3β/Src family tyrosine kinase signaling pathway. Antioxid. Redox Signal. 40, 598–615.
Get full access to this article
View all access options for this article.
References
1.
AvgerinosKI, SpyrouN, MantzorosCS, et al.Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism, 2019; 92:121–135; doi: 10.1016/j.metabol.2018.11.001
2.
BaeSH, SungSH, OhSY, et al.Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab, 2013; 17(1):73–84; doi: 10.1016/j.cmet.2012.12.002
3.
BaiY, ChenQ, SunY-P, et al.Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation. Cardiovasc Ther, 2017; 35(5):12277; doi: 10.1111/1755-5922.12277
4.
BashllariR, MoloniaMS, MuscaràC, et al.Cyanidin-3-O-glucoside protects intestinal epithelial cells from palmitate-induced lipotoxicity. Arch Physiol Biochem, 2023; 129(2):379–386; doi: 10.1080/13813455.2020.1828480
5.
BrandMD. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med, 2016; 100:14–31; doi: 10.1016/j.freeradbiomed.2016.04.001
6.
BudanovAV, LeeJH, KarinM. Stressin’ Sestrins take an aging fight. EMBO Mol Med, 2010; 2(10):388–400; doi: 10.1002/emmm.201000097
7.
CarvalhoC, SantosRX, CardosoS, et al.Doxorubicin: The good, the bad and the ugly effect. Curr Med Chem, 2009; 16(25):3267–3285.
8.
ChenRC, XuXD, Zhi LiuX, et al.Total flavonoids from Clinopodium chinense (Benth.) O. Ktze protect against doxorubicin-induced cardiotoxicity in vitro and in vivo. Evid Based Complement Alternat Med, 2015; 2015:472565; doi: 10.1155/2015/472565
9.
ChenX, LiuJ, ChenSY. Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response. Br J Pharmacol, 2013; 169(2):437–448; doi: 10.1111/bph.12133
10.
ChengY, ZhangJ, GuoW, et al.Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy. Free Radic Biol Med, 2016; 93; doi: 10.1016/j.freeradbiomed.2016.02.002
11.
CoxJ, PennN, MasoodM, et al.Drug overdose—A hidden hazard of obesity. J R Soc Med, 1987; 80(11):708–709.
12.
DaiX, YanX, ZengJ, et al.Elevating CXCR7 improves angiogenic function of EPCs via Akt/GSK-3β/Fyn-mediated Nrf2 activation in diabetic limb ischemia. Circ Res, 2017; 120(5):e7–e23; doi: 10.1161/CIRCRESAHA.117.310619
13.
DamianiRM, MouraDJ, ViauCM, et al.Pathways of cardiac toxicity: Comparison between chemotherapeutic drugs doxorubicin and mitoxantrone. Arch Toxicol, 2016; 90(9):2063–2076; doi: 10.1007/s00204-016-1759-y
14.
DannSG, SelvarajA, ThomasG. mTOR complex1-S6K1 signaling: At the crossroads of obesity, diabetes and cancer. Trends Mol Med, 2007; 13(6):252–259.
15.
FanY, XingY, XiongL, et al.Sestrin2 overexpression alleviates hydrogen peroxide-induced apoptosis and oxidative stress in retinal ganglion cells by enhancing Nrf2 activation via Keap1 downregulation. Chem Biol Interact, 2020; 324:109086; doi: 10.1016/j.cbi.2020.109086
16.
FangCX, DongF, ThomasDP, et al.Hypertrophic cardiomyopathy in high-fat diet-induced obesity: Role of suppression of forkhead transcription factor and atrophy gene transcription. Am J Physiol Heart Circ Physiol, 2008; 295(3):H1206–H1215; doi: 10.1152/ajpheart.00319.2008
17.
GlaysherMA, MohanarubanA, PrechtlCG, et al.A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. BMJ Open, 2017; 7(11):e018598; doi: 10.1136/bmjopen-2017-018598
18.
GuJ, ChengY, WuH, et al.Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy. Diabetes, 2017; 66(2):529–542; doi: 10.2337/db15-1274
19.
GuJ, WangS, GuoH, et al.Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis. Cell Death Dis, 2018; 9(2):82; doi: 10.1038/s41419-017-0093-5
20.
HatemSN, RedheuilA, GandjbakhchE. Cardiac adipose tissue and atrial fibrillation: The perils of adiposity. Cardiovasc Res, 2016; 109(4):502–509; doi: 10.1093/cvr/cvw001
21.
HuX, LiuH, WangZ, et al.miR-200a attenuated doxorubicin-induced cardiotoxicity through upregulation of Nrf2 in mice. Oxid Med Cell Longev, 2019; 2019:1512326; doi: 10.1155/2019/1512326
22.
HydockDS, LienC-Y, JensenBT, et al.Switching to a low-fat diet attenuates the intensified doxorubicin cardiotoxicity associated with high-fat feeding. Cancer Chemother Pharmacol, 2013; 71(6):1551–1560; doi: 10.1007/s00280-013-2154-5
23.
JeonS-M, ParkYB, ChoiM-S. Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin Nutr, 2004; 23(5):1025–1034.
KeizerHG, PinedoHM, SchuurhuisGJ, et al.Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther, 1990; 47(2):219–231.
26.
KimGT, LeeSH, KimJI, et al.Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner. Int J Mol Med, 2014; 33(4):863–869; doi: 10.3892/ijmm.2014.1658
27.
KimballSR, RaviS, GordonBS, et al.Amino acid-induced activation of mTORC1 in rat liver is attenuated by short-term consumption of a high-fat diet. J Nutr, 2015; 145(11):2496–2502; doi: 10.3945/jn.115.215491
28.
KishimotoY, KondoK, MomiyamaY. The protective role of sestrin2 in atherosclerotic and cardiac diseases. Int J Mol Sci, 2021; 22(3):1200; doi: 10.3390/ijms22031200
29.
KleszczyńskiK, ErnstIMA, WagnerAE, et al.Sulforaphane and phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: role of Nrf2-dependent gene expression and antioxidant enzymes. Pharmacol Res, 2013; 78:28–40; doi: 10.1016/j.phrs.2013.09.009
KurstjensS, van DiepenJA, Overmars-BosC, et al.Magnesium deficiency prevents high-fat-diet-induced obesity in mice. Diabetologia, 2018; 61(9):2030–2042; doi: 10.1007/s00125-018-4680-5
32.
LeeES, KwonM-H, KimHM, et al.Curcumin analog CUR5–8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. Metabolism, 2020; 103:154015; doi: 10.1016/j.metabol.2019.154015
33.
LiR, HuangY, SempleI, et al.Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity. Am J Physiol Heart Circ Physiol, 2019; 317(1):H39–H48; doi: 10.1152/ajpheart.00008.2019
34.
LiuJ, HongY, D'AgostinoRB, et al.Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA, 2004; 291(21):2591–2599.
35.
LiuS-Y, LeeY-J, LeeT-C. Association of platelet-derived growth factor receptor β accumulation with increased oxidative stress and cellular injury in sestrin 2 silenced human glioblastoma cells. FEBS Lett, 2011; 585(12):1853–1858; doi: 10.1016/j.febslet.2011.04.041
36.
MaysamiS, HaleyMJ, GorenkovaN, et al.Prolonged diet-induced obesity in mice modifies the inflammatory response and leads to worse outcome after stroke. J Neuroinflammation, 2015; 12:140; doi: 10.1186/s12974-015-0359-8
37.
MinottiG, MennaP, SalvatorelliE, et al.Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev, 2004; 56(2):185–229.
38.
MitraMS, DonthamsettyS, WhiteB, et al.High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity. Toxicol Appl Pharmacol, 2008; 231(3):413–422; doi: 10.1016/j.taap.2008.05.006
39.
MoulinM, PiquereauJ, MateoP, et al.Sexual dimorphism of doxorubicin-mediated cardiotoxicity: Potential role of energy metabolism remodeling. Circ Heart Fail, 2015; 8(1):98–108; doi: 10.1161/CIRCHEARTFAILURE.114.001180
40.
MukhopadhyayP, RajeshM, BátkaiS, et al.Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol, 2009; 296(5):H1466–H1483; doi: 10.1152/ajpheart.00795.2008
41.
OshimaM, PechbertyS, BelliniL, et al.Stearoyl CoA desaturase is a gatekeeper that protects human beta cells against lipotoxicity and maintains their identity. Diabetologia, 2020; 63(2):395–409; doi: 10.1007/s00125-019-05046-x
42.
ParmigianiA, NourbakhshA, DingB, et al.Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep, 2014; 9(4):1281–1291.
43.
RamachandraCJA, CongS, ChanX, et al.Oxidative stress in cardiac hypertrophy: From molecular mechanisms to novel therapeutic targets. Free Radic Biol Med, 2021; 166:297–312; doi: 10.1016/j.freeradbiomed.2021.02.040
44.
RodvoldKA, RushingDA, TewksburyDA. Doxorubicin clearance in the obese. J Clin Oncol, 1988; 6(8):1321–1327.
45.
RussoM, SpagnuoloC, RussoGL, et al.Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment. Crit Rev Food Sci Nutr, 2018; 58(8):1391–1405; doi: 10.1080/10408398.2016.1259983
46.
SalehY, AbdelkarimO, HerzallahK, et al.Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment. Heart Fail Rev, 2021; 26(5):1159–1173; doi: 10.1007/s10741-020-09968-2
47.
SingalPK, LiT, KumarD, et al.Adriamycin-induced heart failure: Mechanism and modulation. Mol Cell Biochem, 2000; 207(1–2):77–86.
48.
SuX, WangS, ZhangH, et al.Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification. J Cell Mol Med, 2021; 25(9):4408–4419; doi: 10.1111/jcmm.16504
49.
SunX, HanF, LuQ, et al.Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet-induced obese mice. Diabetes, 2020; 69(6):1292–1305; doi: 10.2337/db19-0991
50.
ThornCF, OshiroC, MarshS, et al.Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenet Genomics, 2011; 21(7):440–446; doi: 10.1097/FPC.0b013e32833ffb56
51.
TimolatiF, OttD, PentassugliaL, et al.Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. J Mol Cell Cardiol, 2006; 41(5):845–854.
52.
TongLJ, FlachEJ, SheppardMN, et al.Fatal arrhythmogenic right ventricular cardiomyopathy in 2 related subadult chimpanzees (Pan troglodytes). Vet Pathol, 2014; 51(4):858–867; doi: 10.1177/0300985813501333
53.
TongW-H, OllivierreH, NoguchiA, et al.Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia. Heliyon, 2022; 8(8):e10371; doi: 10.1016/j.heliyon.2022.e10371
54.
VejpongsaP, YehETH. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J Am Coll Cardiol, 2014; 64(9):938–945; doi: 10.1016/j.jacc.2014.06.1167
55.
WangAJ, TangY, ZhangJ, et al.Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2. Redox Biol, 2022; 52:102310; doi: 10.1016/j.redox.2022.102310
56.
WangAJ, ZhangJ, XiaoM, et al.Molecular mechanisms of doxorubicin-induced cardiotoxicity: Novel roles of sirtuin 1-mediated signaling pathways. Cell Mol Life Sci, 2021a;78(7):3105–3125; doi: 10.1007/s00018-020-03729-y
57.
WangD, YinY, WangS, et al.FGF1 prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression. Signal Transduct Target Ther, 2021b;6(1):133; doi: 10.1038/s41392-021-00542-2
58.
WangP, LanR, GuoZ, et al.Histone demethylase JMJD3 mediated doxorubicin-induced cardiomyopathy by suppressing SESN2 expression. Front Cell Dev Biol, 2020; 8:548605; doi: 10.3389/fcell.2020.548605
59.
WangP, WangL, LuJ, et al.SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function. J Mol Cell Cardiol, 2019; 133:125–137; doi: 10.1016/j.yjmcc.2019.06.005
60.
WangS, GuJ, XuZ, et al.Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway. J Cell Mol Med, 2017; 21(6):1182–1192; doi: 10.1111/jcmm.13050
61.
WangS, LuoM, ZhangZ, et al.Zinc deficiency exacerbates while zinc supplement attenuates cardiac hypertrophy in high-fat diet-induced obese mice through modulating p38 MAPK-dependent signaling. Toxicol Lett, 2016; 258:134–146; doi: 10.1016/j.toxlet.2016.06.020
62.
XiaoM, TangY, WangJ, et al.A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity. Redox Biol, 2022; 49:102219; doi: 10.1016/j.redox.2021.102219
63.
XinY, BaiY, JiangX, et al.Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway. Redox Biol, 2018; 15:405–417; doi: 10.1016/j.redox.2017.12.016
64.
XiongX-Q, GengZ, ZhouB, et al.FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism, 2018; 83:31–41; doi: 10.1016/j.metabol.2018.01.013
65.
XuL-J, ChenR-C, MaX-Y, et al.Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation. Phytomedicine, 2020; 68:153169; doi: 10.1016/j.phymed.2020.153169
66.
YuJ, WangC, KongQ, et al.Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products. Phytomedicine, 2018a;40:125–139; doi: 10.1016/j.phymed.2018.01.009
67.
YuY, DuH, WeiS, et al.Adipocyte-derived exosomal MiR-27a induces insulin resistance in skeletal muscle through repression of PPARγ. Theranostics, 2018b;8(8):2171–2188; doi: 10.7150/thno.22565
68.
ZhangLL, ZhangZJ. Sestrin2 aggravates oxidative stress of neurons by decreasing the expression of Nrf2. Eur Rev Med Pharmacol Sci, 2018; 22(11):3493–3501; doi: 10.26355/eurrev_201806_15176
69.
ZhangS, LiuX, Bawa-KhalfeT, et al.Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med, 2012; 18(11):1639–1642; doi: 10.1038/nm.2919
70.
ZhangX, HuC, KongC-Y, et al.FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ, 2020; 27(2):540–555; doi: 10.1038/s41418-019-0372-z
71.
ZhangZ, WangS, ZhouS, et al.Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway. J Mol Cell Cardiol, 2014; 77:42–52; doi: 10.1016/j.yjmcc.2014.09.022
72.
ZhuH, YangY, WangY, et al.MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res, 2011; 92(1):75–84; doi: 10.1093/cvr/cvr145
73.
ZhuY, KimSQ, ZhangY, et al.Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake. Metabolism, 2021; 123:154861; doi: 10.1016/j.metabol.2021.154861
74.
ZhuoX, WuY, YangY, et al.Knockdown of LSD1 meliorates Ox-LDL-stimulated NLRP3 activation and inflammation by promoting autophagy via SESN2-mesiated PI3K/Akt/mTOR signaling pathway. Life Sci, 2019; 233:116696; doi: 10.1016/j.lfs.2019.116696
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
